Marina Udier
Directeur/Membre du Conseil chez CELYAD ONCOLOGY SA
Postes actifs de Marina Udier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Directeur/Membre du Conseil | 11/01/2011 | - |
| Independent Dir/Board Member | 11/01/2011 | - | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | 01/01/2016 | - |
| Directeur Général | 01/05/2019 | - | |
| Directeur des opérations | 01/01/2016 | 26/02/2020 | |
| Nouscom Srl | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - |
Historique de carrière de Marina Udier
Anciens postes connus de Marina Udier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Directeur des opérations | 01/01/2016 | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Formation de Marina Udier
| Yale University | Doctorate Degree |
Statistiques
Internationale
| Suisse | 3 |
| Etats-Unis | 3 |
| Belgique | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
| Nouscom Srl | Commercial Services |
- Bourse
- Insiders
- Marina Udier
- Expérience
